Over the last 90 days, previous to the date of this filing, there have been 40 insider transactions from the activities of 7 individual insiders all of which have been purchases and resulted in the acquisition of 4,405,250 company shares. Relative to the preceding 90-day window of time, there were 19 transactions from 2 insiders which resulted in the net acquisition of 917,232 shares.
This level of insider transactions is higher than the peer group average for the 150-company Pharmaceuticals peer group over the last 90-day period. Peer group activity averaged 36.3 transactions per company, and disposition by insiders of 6,768 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/944809/000120919119040733/xslF345X03/doc4.xml
|Wall Street Sees Narrowly Mixed Open Ahead of Rate D...|
|Analyst Actions: UBS Lifts AutoZone's Price Target t...|
|Sector Update: Top Consumer Stocks Mostly Gain Pre-B...|
|--Analyst Actions: Credit Suisse Raises AutoZone's P...|
|Analyst Actions: Nomura Raises AutoZone's Price Targ...|